Aonong Bio fined 5.65 million yuan for failing to disclose 906 million yuan in litigation
Chinese agricultural biotech firm Aonong Bio was fined 5.65 million yuan by the Fujian Securities Regulatory Bureau for failing to timely disclose 206 major litigation and arbitration cases involving 906 million yuan and related-party transactions of 160 million yuan. Former chairman Wu Youlin and other executives were also fined. The company's stock fell for five consecutive days, closing at 2.89 yuan per share, amid ongoing financial losses.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Reporting timeline
Aonong Biological Board Secretary Fined 1.05 Million Yuan for Disclosure Failures
The Fujian Securities Regulatory Bureau has fined Peng Jiang, former Board Secretary of Aonong Biological (603363.SH), 1.05 million yuan for failing to fulfill his duties diligently. The penalty stems from the company's failure to disclose major litigation, arbitration, and related-party transactions as required by securities regulations. The CSRC initiated an investigation in April 2026, and a formal administrative penalty decision was issued after a prior notice in September 2026. Peng Jiang, who served as Board Secretary from January 2024 to August 2026 and also held roles as Deputy General Manager and head of legal affairs, was found to have been aware of these events but did not organize timely disclosure. The fine is approximately two-thirds of his combined pre-tax compensation of 629,000 yuan in 2024 and 941,300 yuan in 2025. The report is attributed to the Times Business Research Institute and was published on NetEase Finance.
Read sourceFujian's Aonong Bio Fined 2.5 Million Yuan for Information Disclosure Violations
On September 18, Fujian Aonong Biotechnology Group Co., Ltd. (Aonong Bio) was penalized by the Fujian Securities Regulatory Bureau for two information disclosure violations. The first violation involved failing to disclose major litigation and arbitration cases in a timely manner, with undisclosed amounts reaching 58.76% of net assets. The second violation involved failing to disclose related-party transactions totaling approximately 160.47 million yuan, or 31.89% of net assets. The company was fined 2.5 million yuan, and four responsible individuals, including former Chairman Wu Youlin and current Chairman Su Mingcheng, were fined a total of 3.15 million yuan. The Shanghai Stock Exchange also issued disciplinary measures. The company had previously been under CSRC investigation since April 2026, shortly after removing delisting risk warnings in May 2025. Aonong Bio has experienced consecutive losses from 2021 to 2023 and entered bankruptcy reorganization in 2024. Its 2025 annual report showed a sharp 86.60% decline in net profit, and the 2026 semi-annual report recorded a net loss of 190 million yuan. The stock price closed at 2.89 yuan per share on September 18, declining for five consecutive trading days.
Read sourceAonong Bio fined 5.65 million yuan for failing to disclose 906 million yuan in litigation
On September 18, the Fujian Securities Regulatory Bureau penalized Aonong Biological for failing to timely disclose major litigation, arbitration cases, and related-party transactions. The company was ordered to rectify, issued a warning, and fined 2.5 million yuan. Four responsible individuals, including former Chairman Wu Youlin and CFO Yang Zhou, were collectively fined 3.15 million yuan, bringing total fines to 5.65 million yuan. Between June 2024 and February 2025, 206 out of 319 litigation cases were not disclosed on time, involving approximately 906 million yuan. Additionally, from January to March 2025, the company failed to disclose related-party transactions totaling 160 million yuan. The regulator cited mitigating factors such as admission of guilt. Aonong Biological stated the fine will impact current net profit but not materially affect operations. The company's share price has fallen 37.31% year-to-date, and its first-half 2026 net profit turned to a loss of 190 million yuan.
Read sourceShow 2 older updatesHide older updates
Aonong Bio Fined 5.65 Million Yuan for Failure to Disclose Lawsuits and Related-Party Transactions
The Fujian Securities Regulatory Bureau has fined Aonong Bio a total of 5.65 million yuan for failing to disclose major litigation, arbitration, and related-party transactions as required. According to the Administrative Penalty Decision, between June 2024 and February 2025, the company disclosed 206 lawsuits and arbitration cases late, involving a total of 905 million yuan, which in some instances accounted for over 58% of its audited net assets. Additionally, from January to March 2025, Aonong Bio failed to disclose related-party transactions totaling 160.4659 million yuan. The regulator ordered the company to correct the issues, issued warnings, and imposed fines on the company and several executives, including former Chairman Wu Youlin, who was fined 1.4 million yuan. Aonong Bio stated the fine will impact its current net profit but not its production or financial condition, and it apologized to investors, pledging to improve internal governance and information disclosure quality.
Aonong Bio Fined for Disclosure Violations; Stock Falls for Five Consecutive Days
Aonong Bio, a Chinese agricultural biotechnology company, has been penalized by the Fujian Securities Regulatory Bureau for two information disclosure violations. The company failed to timely disclose major litigation and arbitration cases between June 2024 and February 2025, involving amounts up to 58.76% of its net assets. It also failed to disclose related-party transactions totaling approximately RMB 160 million from January to March 2025. This is not the first such violation; a warning was issued in September 2024. The bureau ordered corrections, issued a warning, and imposed a fine of RMB 2.5 million on the company. Former chairman Wu Youlin and board secretary Peng Jiang were fined RMB 1.4 million and RMB 1.05 million respectively. New chairman Su Mingcheng was fined RMB 500,000, and CFO Yang Zhou was fined RMB 200,000. In the first half of the year, Aonong Bio reported a net loss of RMB 190 million, turning from profit to loss, amid declining pork prices. The stock has fallen for five consecutive trading days, closing at RMB 2.89 per share.
Read source